Form 4: Medtronic Executive Reports Tax-Related Share Disposition
Statement of Changes in Beneficial Ownership
SVP and Chief HR Officer Matthew R. Walter disposed of 2,840 shares of Medtronic plc to satisfy tax withholding obligations.
Summary
- Matthew R. Walter, SVP and Chief HR Officer at Medtronic plc, reported the disposition of 2,840 ordinary shares.
- The transaction occurred on June 4, 2026, at a price of $83.32 per share.
- The shares were withheld by the company to cover tax obligations related to the vesting of performance-based restricted stock units on April 24, 2026.
- Following this transaction, the reporting person maintains a direct beneficial ownership of 38,689 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative tax settlement rather than a strategic shift or market-driven divestment.
Positives
- The transaction was a routine tax withholding event rather than a discretionary open-market sale, indicating continued executive retention of the remaining 38,689 shares.
Negatives
- Reduction in the total number of shares held directly by the executive.
Risks
- None identified; this is a standard administrative transaction related to equity compensation.
Future Outlook
No forward-looking guidance or strategic outlook provided in this filing.
Industry Context
StockSavvy.ai notes that tax-related share withholding is a standard practice in executive compensation packages across the medical device and broader healthcare sector, and does not typically signal a change in management sentiment regarding company performance.
Comparison to Industry Standards
- The transaction aligns with standard corporate governance practices for equity-based compensation among large-cap healthcare companies like Abbott Laboratories or Boston Scientific.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a standard tax-related equity settlement.
Next Steps
- None indicated.
Key Dates
| Date | Description |
|---|---|
| 2026-04-24 | Vesting date of performance-based restricted stock units. |
| 2026-06-04 | Transaction date for the withholding of shares for tax purposes. |
| 2026-06-08 | Date of filing for the Form 4 statement. |
Keywords
Medtronic, MDT, Insider Trading, Form 4, Executive Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.